Q3 2019 TG Therapeutics Inc Earnings Call Transcript
Greetings. Welcome to TG Therapeutics' Third Quarter 2019 Financial Results and Business Update Call.
(Operator Instructions)
Please note that this conference is being recorded.
At this time, I'll turn the call over to Jenna Bosco. Jenna, you may now begin.
Thank you. Good morning and welcome to our conference call regarding TG Therapeutics' Third Quarter 2019 Financial Results and Business Update. I'm Jenna Bosco, TG's Senior Vice President of Corporate Communications, and I welcome you to our conference call today.
Following our safe harbor statement, Sean Power, TG's Chief Financial Officer, will provide a brief overview of our financial results and then turn the call over to Michael Weiss, the company's Executive Chairman and Chief Executive Officer, who will provide an update on the ongoing development of our lead compounds ublituximab and umbralisib as well as an overview of our overall company standing.
Before we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |